이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Advanced Enzyme Technologies 과거 수익 실적
과거 기준 확인 4/6
Advanced Enzyme Technologies의 수입은 연평균 -1.3%의 비율로 감소해 온 반면, Chemicals 산업은 수입이 연평균 16%의 비율로 증가했습니다. 매출은 연평균 7.2%의 비율로 증가해 왔습니다. Advanced Enzyme Technologies의 자기자본이익률은 10%이고 순이익률은 21.4%입니다.
주요 정보
-1.3%
수익 성장률
-1.4%
EPS 성장률
| Chemicals 산업 성장 | 17.7% |
| 매출 성장률 | 7.2% |
| 자기자본 수익률 | 10.0% |
| 순이익 | 21.4% |
| 최근 수익 업데이트 | 31 Mar 2024 |
최근 과거 실적 업데이트
Recent updates
Advanced Enzyme Technologies (NSE:ADVENZYMES) Has Affirmed Its Dividend Of ₹1.00
Jul 13
Advanced Enzyme Technologies' (NSE:ADVENZYMES) Returns On Capital Not Reflecting Well On The Business
Apr 08Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends
Sep 23Advanced Enzyme Technologies (NSE:ADVENZYMES) Could Be Struggling To Allocate Capital
Feb 03Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends
Aug 11With EPS Growth And More, Advanced Enzyme Technologies (NSE:ADVENZYMES) Is Interesting
May 13Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Paint A Concerning Picture
Mar 28The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 185%, So Why Not Pay It Some Attention?
Mar 13Don't Ignore The Fact That This Insider Just Sold Some Shares In Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)
Feb 21Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Feb 18I Built A List Of Growing Companies And Advanced Enzyme Technologies (NSE:ADVENZYMES) Made The Cut
Feb 03
What Kind Of Investors Own Most Of Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)?
Jan 19What Do The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Tell Us?
Dec 28The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 114%, So Why Not Pay It Some Attention?
Dec 13Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?
Nov 28Are Strong Financial Prospects The Force That Is Driving The Momentum In Advanced Enzyme Technologies Limited's NSE:ADVENZYMES) Stock?
Nov 20Here's Why I Think Advanced Enzyme Technologies (NSE:ADVENZYMES) Might Deserve Your Attention Today
Nov 05What You Need To Know About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Investor Composition
Oct 21Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?
Oct 06Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Stocks Shoot Up 31% But Its P/E Still Looks Reasonable
Sep 26Our Take On The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES)
Sep 21Does Advanced Enzyme Technologies (NSE:ADVENZYMES) Have A Healthy Balance Sheet?
Sep 08Have Insiders Sold Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Shares Recently?
Aug 26Why We're Not Concerned About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Share Price
Aug 21Introducing Advanced Enzyme Technologies (NSE:ADVENZYMES), A Stock That Climbed 60% In The Last Year
Aug 20수익 및 비용 분석
수익 및 비용 분석
Advanced Enzyme Technologies 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.
수익 및 매출 내역
| 날짜 | 수익 | 수익 | G+A 비용 | R&D 비용 |
|---|---|---|---|---|
| 31 Mar 24 | 6,239 | 1,333 | 1,361 | 0 |
| 31 Dec 23 | 6,048 | 1,371 | 1,327 | 0 |
| 30 Sep 23 | 5,859 | 1,248 | 1,296 | 0 |
| 30 Jun 23 | 5,668 | 1,166 | 1,257 | 0 |
| 31 Mar 23 | 5,406 | 1,056 | 1,217 | 0 |
| 31 Dec 22 | 5,337 | 979 | 1,167 | 0 |
| 30 Sep 22 | 5,251 | 960 | 1,131 | 0 |
| 30 Jun 22 | 5,135 | 995 | 1,111 | 0 |
| 31 Mar 22 | 5,294 | 1,196 | 1,099 | 0 |
| 31 Dec 21 | 5,309 | 1,268 | 1,040 | 0 |
| 30 Sep 21 | 5,350 | 1,424 | 1,000 | 0 |
| 30 Jun 21 | 5,325 | 1,500 | 930 | 0 |
| 31 Mar 21 | 5,018 | 1,459 | 898 | 0 |
| 31 Dec 20 | 4,820 | 1,459 | 891 | 0 |
| 30 Sep 20 | 4,569 | 1,364 | 868 | 0 |
| 30 Jun 20 | 4,481 | 1,301 | 859 | 0 |
| 31 Mar 20 | 4,440 | 1,293 | 852 | 0 |
| 31 Dec 19 | 4,480 | 1,302 | 871 | 0 |
| 30 Sep 19 | 4,366 | 1,210 | 900 | 0 |
| 30 Jun 19 | 4,288 | 1,148 | 891 | 0 |
| 31 Mar 19 | 4,220 | 1,111 | 888 | 0 |
| 31 Dec 18 | 4,194 | 1,061 | 873 | 0 |
| 30 Sep 18 | 4,261 | 1,068 | 838 | 0 |
| 30 Jun 18 | 4,199 | 1,039 | 737 | 0 |
| 31 Mar 18 | 3,918 | 901 | 752 | 0 |
| 31 Dec 17 | 3,660 | 837 | 687 | 0 |
| 30 Sep 17 | 3,213 | 725 | 624 | 0 |
| 30 Jun 17 | 3,127 | 793 | 592 | 0 |
| 31 Mar 17 | 3,290 | 915 | 546 | 0 |
| 31 Dec 16 | 3,260 | 942 | 536 | 0 |
| 30 Sep 16 | 3,404 | 998 | 521 | 0 |
| 30 Jun 16 | 3,184 | 854 | 489 | 0 |
| 31 Mar 16 | 2,938 | 759 | 486 | 0 |
| 31 Mar 15 | 2,233 | 510 | 401 | 0 |
| 31 Mar 14 | 2,397 | 201 | 365 | 0 |
양질의 수익: ADVENZYMES 은 높은 수익을 보유하고 있습니다.
이익 마진 증가: ADVENZYMES 의 현재 순이익 이익률 (21.4%) 작년보다 높습니다 (19.5%).
잉여현금흐름 대 수익 분석
과거 수익 성장 분석
수익추이: ADVENZYMES 의 수입은 지난 5년 동안 매년 1.3% 씩 감소했습니다.
성장 가속화: 지난 1년간 ADVENZYMES 의 수익 증가율( 26.2% )은 연간 평균( -1.3% 초과합니다. ).
수익 대 산업: 지난 1년간 ADVENZYMES 수익 증가율( 26.2% )은 Chemicals 업계 -0.2% 초과했습니다.
자기자본 수익률
높은 ROE: ADVENZYMES 의 자본 수익률( 10% )은 낮음으로 간주됩니다.